■ Demo— not a validated GxP system — synthetic data

Affinis

Compound registry

KIN-07 · EGFR mutant-selective — structures, computed properties and batches

Register a compound…
Series
Status
Registered compounds, with their computed properties and mutant-EGFR potency
StructureCompoundSeriesR-groupsFormulaMWcLogPTPSA (Ų)BatchespIC50 mutStatus
NHNNAFN-003300BR1 H · R6 H · R7 HC14H11N3221.33.3737.80—designed
NHNNOAFN-003301BR1 H · R6 H · R7 OMeC15H13N3O251.33.3847.00—designed
NHNNOAFN-003302BR1 H · R6 H · R7 OEtC16H15N3O265.33.7747.00—designed
NHNNOOAFN-003303BR1 H · R6 H · R7 OCH2CH2OMeC17H17N3O2295.33.4056.30—designed
NHNNFAFN-003304BR1 H · R6 H · R7 FC14H10FN3239.33.5137.80—designed
NHNNONOAFN-003305BR1 H · R6 H · R7 O(CH2)2-morpholinoC20H22N4O2350.43.0859.50—designed
NHNNClAFN-003306BR1 H · R6 H · R7 ClC14H10ClN3255.74.0337.80—designed
NHNNOHAFN-003307BR1 H · R6 H · R7 OHC14H11N3O237.33.0858.015.53tested
NHNNOAFN-003308BR1 H · R6 OMe · R7 HC15H13N3O251.33.3847.00—designed
NHNNOOAFN-003309BR1 H · R6 OMe · R7 OMeC16H15N3O2281.33.3956.30—designed
NHNNOOAFN-003310BR1 H · R6 OMe · R7 OEtC17H17N3O2295.33.7856.30—designed
NHNNOOOAFN-003311BR1 H · R6 OMe · R7 OCH2CH2OMeC18H19N3O3325.43.4165.516.38tested
NHNNOFAFN-003312BR1 H · R6 OMe · R7 FC15H12FN3O269.33.5247.015.77tested
NHNNOONOAFN-003313BR1 H · R6 OMe · R7 O(CH2)2-morpholinoC21H24N4O3380.43.0968.70—designed
NHNNOClAFN-003314BR1 H · R6 OMe · R7 ClC15H12ClN3O285.74.0447.016.18tested
NHNNOOHAFN-003315BR1 H · R6 OMe · R7 OHC15H13N3O2267.33.0967.30—designed
NHNNOAFN-003316BR1 H · R6 OEt · R7 HC16H15N3O265.33.7747.00—designed
NHNNOOAFN-003317BR1 H · R6 OEt · R7 OMeC17H17N3O2295.33.7856.30—designed
NHNNOOAFN-003318BR1 H · R6 OEt · R7 OEtC18H19N3O2309.44.1756.30—designed
NHNNOOOAFN-003319BR1 H · R6 OEt · R7 OCH2CH2OMeC19H21N3O3339.43.8065.516.04tested
NHNNOFAFN-003320BR1 H · R6 OEt · R7 FC16H14FN3O283.33.9147.015.79tested
NHNNOONOAFN-003321BR1 H · R6 OEt · R7 O(CH2)2-morpholinoC22H26N4O3394.53.4868.70—designed
NHNNOClAFN-003322BR1 H · R6 OEt · R7 ClC16H14ClN3O299.84.4347.015.86tested
NHNNOOHAFN-003323BR1 H · R6 OEt · R7 OHC16H15N3O2281.33.4867.30—designed
NHNNOOAFN-003324BR1 H · R6 OCH2CH2OMe · R7 HC17H17N3O2295.33.4056.315.91tested
NHNNOOOAFN-003325BR1 H · R6 OCH2CH2OMe · R7 OMeC18H19N3O3325.43.4165.50—designed
NHNNOOOAFN-003326BR1 H · R6 OCH2CH2OMe · R7 OEtC19H21N3O3339.43.8065.50—designed
NHNNOOOOAFN-003327BR1 H · R6 OCH2CH2OMe · R7 OCH2CH2OMeC20H23N3O4369.43.4274.70—designed
NHNNOOFAFN-003328BR1 H · R6 OCH2CH2OMe · R7 FC17H16FN3O2313.33.5456.30—designed
NHNNOOONOAFN-003329BR1 H · R6 OCH2CH2OMe · R7 O(CH2)2-morpholinoC23H28N4O4424.53.1178.00—designed
NHNNOOClAFN-003330BR1 H · R6 OCH2CH2OMe · R7 ClC17H16ClN3O2329.84.0556.30—designed
NHNNOOOHAFN-003331BR1 H · R6 OCH2CH2OMe · R7 OHC17H17N3O3311.33.1076.50—designed
NHNNONOAFN-003332BR1 H · R6 O(CH2)3-morpholino · R7 HC21H24N4O2364.43.4759.51—tested
NHNNONOOAFN-003333BR1 H · R6 O(CH2)3-morpholino · R7 OMeC22H26N4O3394.53.4868.716.18tested
NHNNONOOAFN-003334BR1 H · R6 O(CH2)3-morpholino · R7 OEtC23H28N4O3408.53.8768.70—designed
NHNNONOOOAFN-003335BR1 H · R6 O(CH2)3-morpholino · R7 OCH2CH2OMeC24H30N4O4438.53.5078.00—designed
NHNNONOFAFN-003336BR1 H · R6 O(CH2)3-morpholino · R7 FC21H23FN4O2382.43.6159.516.30tested
NHNNONOONOAFN-003337BR1 H · R6 O(CH2)3-morpholino · R7 O(CH2)2-morpholinoC27H35N5O4493.63.1981.20—designed
NHNNONOClAFN-003338BR1 H · R6 O(CH2)3-morpholino · R7 ClC21H23ClN4O2398.94.1359.515.98tested
NHNNONOOHAFN-003339BR1 H · R6 O(CH2)3-morpholino · R7 OHC21H24N4O3380.43.1879.70—designed
NHNNNHOAFN-003340BR1 H · R6 acrylamido · R7 HC17H14N4O290.33.5066.90—designed
NHNNNHOOAFN-003341BR1 H · R6 acrylamido · R7 OMeC18H16N4O2320.43.5176.10—designed
NHNNNHOOAFN-003342BR1 H · R6 acrylamido · R7 OEtC19H18N4O2334.43.9076.10—designed
NHNNNHOOOAFN-003343BR1 H · R6 acrylamido · R7 OCH2CH2OMeC20H20N4O3364.43.5285.40—designed
NHNNNHOFAFN-003344BR1 H · R6 acrylamido · R7 FC17H13FN4O308.33.6466.90—designed
NHNNNHOONOAFN-003345BR1 H · R6 acrylamido · R7 O(CH2)2-morpholinoC23H25N5O3419.53.2188.60—designed
NHNNNHOClAFN-003346BR1 H · R6 acrylamido · R7 ClC17H13ClN4O324.84.1566.90—designed
NHNNNHOOHAFN-003347BR1 H · R6 acrylamido · R7 OHC17H14N4O2306.33.2087.10—designed
NHNNFAFN-003348BR1 F · R6 H · R7 HC14H10FN3239.33.5137.80—designed
NHNNFOAFN-003349BR1 F · R6 H · R7 OMeC15H12FN3O269.33.5247.01—tested

Properties calculated with RDKit offline, not at runtimeSubstructure: our own screen fingerprint, then VF2 matching — no RDKit at runtimepIC50 mut = mean of approved fits on ASY-EGFR-TM-03